Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 12Terminated 7Recruiting 3Withdrawn 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Carcinoma, Non-Small-Cell Lung 13Melanoma 11Triple Negative Breast Neoplasms 9Squamous Cell Carcinoma of Head and Neck 8Breast Neoplasms 8Neoplasms 7Head and Neck Neoplasms 7Multiple Myeloma 6Carcinoma, Transitional Cell 6Carcinoma, Renal Cell 6Pancreatic Neoplasms 5Lung Neoplasms 4Recurrence 3Prostatic Neoplasms 3Endometrial Neoplasms 3Colorectal Neoplasms 3Brain Neoplasms 3Stomach Neoplasms 2Sarcoma 2Neoplasm Metastasis 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma 2Kidney Neoplasms 2Inflammatory Breast Neoplasms 2Hematologic Neoplasms 2Glioblastoma 2Urothelial Cancer 1Thyroid Neoplasms 1Subcutaneous panniculitis-like T-cell lymphoma 1Spinocerebellar Degenerations 1

Interventions

Cyclophosphamide 12Rituximab 10Peripheral Blood Stem Cell Transplantation 8fludarabine phosphate 7Etoposide 5fludarabine 4Radiotherapy 4Filgrastim 4Cytarabine 4venetoclax 3ofatumumab 3Whole-Body Irradiation 3Vincristine 3Tacrolimus 3Mycophenolic Acid 3Methotrexate 3Doxorubicin 3Cyclosporine 3Carmustine 3Bendamustine Hydrochloride 3sargramostim 2romidepsin 2idelalisib 2ibrutinib 2ibritumomab tiuxetan 2Saline Solution 2Prednisone 2Pentetic Acid 2Ondansetron 2O(6)-benzylguanine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Lymphoma, Non-Hodgkin × pembrolizumab × Clear all
NCT02408042 2017-06-27

Study of Pembrolizumab With Chemotherapy in Patients With Advanced Lymphoma (PembroHeme)

Western Regional Medical Center

Phase 1/2 Withdrawn
Lymphoid

Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon âš¡